Omega-3 (EPA/DHA) for longevity
Grade ALong-chain marine fatty acids with consistent cardiovascular, neurologic, and inflammatory benefits.
Long-chain marine fatty acids with consistent cardiovascular, neurologic, and inflammatory benefits.
Incorporated into membrane phospholipids; precursors to resolvins and protectins; lower hepatic triglyceride synthesis.
Omega-3 (EPA/DHA) is typically taken orally as triglyceride-form fish oil or algal dha, with largest meal. Incorporated into membrane phospholipids; precursors to resolvins and protectins; lower hepatic triglyceride synthesis. Effective range is 1–4 g, with 2 g EPA/DHA combined being the most-studied dose. Taking it with food improves absorption and reduces GI upset.
Timing (With largest meal) is chosen to match the compound's pharmacokinetics and the physiological pathway it targets. Consistency matters more than the exact hour.
Grade A — multiple randomised human trials or meta-analyses support the primary claim. Dosing, mechanism and safety are well characterised in humans.
The primary references used to grade Omega-3 (EPA/DHA) are listed below. Cross-check against the current literature and expect the grade to move as new human trials publish.
Further reading: Research library → · Protocols →
Common questions about dose, benefits, side effects and longevity use of Omega-3 (EPA/DHA).
2 g EPA/DHA combined is the most-studied dose, with a full effective range of 1–4 g. Take it with largest meal, with food.
Incorporated into membrane phospholipids; precursors to resolvins and protectins; lower hepatic triglyceride synthesis.
Subjective effects can appear in 1–3 weeks. Objective biomarker shifts typically require 8–12 weeks of consistent dosing, which is why baseline and 12-week labs are recommended.
Yes — Omega-3 (EPA/DHA) is best taken with a meal containing some fat to maximise absorption and reduce GI upset.
Fishy reflux; Mild platelet effects at high doses. Avoid in: Bleeding disorders without supervision.
Most users run Omega-3 (EPA/DHA) continuously and reassess every 12 weeks. A short wash-out can restore responsiveness if effects plateau. Long-term dosing should be paired with periodic bloods.
Commonly stacked with: Vitamin D3, Astaxanthin. Introduce one compound at a time to preserve attribution of effect and side effect.
Look for third-party testing (NSF, Informed Sport, USP), a standardised active compound on the label, a clear country of origin, and dose-per-serving that matches the researched range.
| Attribute | Omega-3 (EPA/DHA)This page | Creatine Monohydrate | Magnesium Glycinate |
|---|---|---|---|
| Evidence | Grade A91/100 | Grade A94/100 | Grade A89/100 |
| Category | Cardiovascular | Cognition | Sleep |
| Best for | Triglyceride reduction | Strength and lean mass | Improved sleep latency and HRV |
| Typical dose | 2 g EPA/DHA combined | 5 g daily | 300–400 mg elemental PM |
| Timing | With largest meal | Any time of day, consistent | 60 min before bed |
| Form | Triglyceride-form fish oil or algal DHA | Micronized powder | Capsule or powder |
| Action | Current page | View → | View → |